SLU-PP-332+BAM15 Protocol: How to Cycle It, Timing & What to Expect

Protocol snapshot

• Typical cycle length: 8 to 12 weeks; 12 to 16 weeks for experienced users; a 4-week trial period is common before committing to a full cycle
• Frequency: SLU-PP-332 once daily in the morning; BAM15 on separate days, typically every other day or on designated rest days
• Common delivery routes: Oral only for both compounds; BAM15 must not be injected
• Key timing notes: The two compounds are intentionally separated by day to prevent excessive simultaneous thermogenesis; SLU-PP-332 is taken at a consistent morning time; BAM15 is timed around rest or off-training days

Who This Protocol Is For

The SLU-PP-332 and BAM15 stack attracts a specific kind of reader: someone already invested in metabolic optimization who has moved past basic supplementation and wants to work at the level of mitochondrial function. The most common goals across community protocols are accelerated fat loss, improved endurance and work capacity, and better metabolic flexibility. People running this stack usually care about body composition in a particular way, not just the number on the scale but visceral fat reduction, waistline changes, and sustained energy during training.

One clarification that shapes how you approach this protocol: neither SLU-PP-332 nor BAM15 is a peptide in the classical sense. SLU-PP-332 is a small-molecule ERR agonist, meaning it activates receptors that control how cells produce energy, much like flipping on a power switch that the body normally reserves for endurance training. BAM15 is a mitochondrial uncoupler, a compound that forces cells to burn fuel as heat rather than convert it to usable energy. They get discussed alongside peptide protocols because the biohacking community uses them in a similar research context, but their mechanisms are fundamentally different from hormone-adjacent compounds, and that difference matters for the protocol.

Because neither works through a pituitary or hormonal feedback loop, the cycling considerations differ from what most peptide users are used to. That distinction, not the administration method, is the key structural difference for protocol design.

Experience level shapes this protocol considerably. Community reports consistently describe this as an intermediate to advanced stack, not because the administration is complicated (both compounds are oral) but because the thermogenic effects of combining two compounds that affect mitochondrial function require careful titration and self-monitoring. Someone who has never tracked their response to any metabolic compound is generally advised to start with one at a time before combining.

Both compounds are oral-only. BAM15 is a lipophilic compound, meaning it dissolves in fat rather than water, and must not be injected under any circumstances. That is a hard boundary, not a preference.

How Is a SLU-PP-332+BAM15 Cycle Structured?

The defining feature of this combination protocol is the split-day design. Rather than taking both compounds on the same day, most approaches keep them on separate days: SLU-PP-332 on training days, BAM15 on rest or recovery days. The reason is mechanistic. SLU-PP-332 builds mitochondrial capacity and drives ATP production. BAM15 forces those mitochondria to burn fuel as heat rather than produce ATP, a process called uncoupling. Running both at high doses simultaneously risks generating excessive thermogenesis while also depleting the ATP that training demands. Separating them by day lets each compound do its job without the two effects working against each other.

Most cycles fall into one of three duration windows. A short assessment cycle of four to eight weeks is common for first-time users who want to gauge individual response before committing to a longer run. Standard cycles run eight to twelve weeks. Longer cycles of twelve to sixteen weeks are also used, particularly among users who have already run shorter cycles and have a clear read on their response.

One practical difference from many other protocol types is that a formal loading phase followed by a lower maintenance phase is not a feature of this stack. The structural equivalent is titration upward from a conservative starting point, and its mechanics are covered in the Loading and Maintenance Phases section below.

How Your Dose Is Determined

What moves a SLU-PP-332+BAM15 dose:

• Your goal: Fat loss and body composition goals typically anchor at a conservative starting point and titrate upward based on thermogenic response. Endurance and metabolic flexibility goals, where the focus is on mitochondrial capacity rather than thermogenesis, tend to lean toward SLU-PP-332 as the primary compound and use BAM15 more sparingly. The split-day ratio shifts depending on which effect matters more.
• Experience level: First-time users sit at the lower end of the range for each compound and often start with one before layering the second. More experienced users who have already gauged their thermogenic response have more room to titrate upward.
• Delivery route: Both compounds are oral-only. BAM15's lipophilic nature and short half-life mean that formulation affects how it behaves, and how it is formulated influences where someone lands on the range.
• Individual response: Thermogenic sensitivity varies considerably. Some users notice significant heat generation and sleep disruption at doses others tolerate easily. How a specific person responds to BAM15's uncoupling effect is one of the primary variables that determines where they land.

There is a practical complication worth understanding before diving into the research. Community reporting for this stack carries a known unit inconsistency, with some sources reporting doses in micrograms and others in milligrams. This is not a simple typo. It reflects genuine variation in formulations, compound purities, and reporting conventions across sources. The dose that makes sense depends entirely on the formulation being used, which is exactly why copying a number from a forum without verifying the unit convention and formulation is one of the most common mistakes in this stack.

There is no single number that fits everyone here. Both the thermogenic ceiling from BAM15 and the mitochondrial response from SLU-PP-332 vary by individual, and the interaction between the two adds another layer of variability. Starting conservatively and titrating based on actual response is the universal theme across every approach to this combination.

Your dose should not be a guess. The MyPeptidePal Protocol Creator takes your goal, your experience with thermogenic compounds, and whether you are running SLU-PP-332 alone or layering in BAM15 on separate days, and builds your SLU-PP-332+BAM15 protocol: your dose, your cycle, and your timing.

Get your protocol at mypeptidepal.ai

How Often Do You Take SLU-PP-332+BAM15?

SLU-PP-332 is typically taken once daily in the morning. The compound works through gene transcription, a process where it activates receptors that switch on genes controlling mitochondrial function, and aligning that activation with the body's natural circadian metabolic rhythms is a consistent recommendation across practitioner and community sources. Avoid taking SLU-PP-332 within five hours of sleep, because the increase in metabolic activity can disrupt sleep quality, particularly in the early weeks of a cycle.

BAM15's frequency is shaped by its short half-life of approximately 1.7 hours. Think of it like a spark rather than a slow burn: the compound flares through the system quickly, which means it does not accumulate, and every-other-day or rest-day use does not create a buildup risk. In practice, most protocols use BAM15 on rest or off-training days, every other day, or on three designated days per week.

Consistency in timing matters more for SLU-PP-332 than for BAM15. Because SLU-PP-332 affects gene transcription, variable daily timing disrupts the circadian alignment that makes the morning dose effective. Taking it at the same time every day is a straightforward discipline that sources consistently emphasize.

The practical weekly pattern from the split-day structure looks something like SLU-PP-332 on training days and BAM15 on rest days. A five-day training week with two rest days produces approximately five SLU-PP-332 days and two BAM15 days. An alternating true daily split is also used but less common.

Loading and Maintenance Phases

This combination does not use a loading phase in the traditional sense. SLU-PP-332 works through gene transcription rather than receptor saturation, so the loading-then-maintenance model that applies to many receptor-targeting compounds does not map onto its mechanism. There is no protocol structure where the dose starts high to front-load the compound and then drops to a lower maintenance level.

What exists instead is titration. Most approaches start at a conservative point and move upward gradually over the first two to four weeks, assessing thermogenic response and tolerability before increasing. Think of it like tuning a dial rather than flipping a switch: the goal is to find the setting that produces the desired thermogenic and performance effect without pushing past what the body manages comfortably. The dose reached through titration is then sustained for the remainder of the cycle rather than stepped back down.

BAM15 follows the same logic. The every-other-day or designated-rest-day frequency stays consistent across the cycle. If the cycle extends beyond eight weeks, the dose does not need to increase to maintain effect. The mitochondrial adaptations SLU-PP-332 promotes are cumulative, and BAM15's uncoupling effect does not diminish with consistent use the way receptor-dependent compounds can.

Off-Cycle Considerations

Neither SLU-PP-332 nor BAM15 requires a mandatory off-cycle break based on the physiological mechanisms involved. SLU-PP-332 operates through gene transcription rather than hormonal feedback, so there is no receptor desensitization or pituitary suppression that demands a reset period. BAM15 clears in under two hours and does not accumulate, so continuous use does not create a buildup concern.

Despite that, voluntary off-cycle periods are consistently recommended in practitioner guidance for a practical reason: without a baseline period, it becomes difficult to assess what the compounds are actually contributing. Users who run continuous cycles without breaks often find it harder to distinguish compound effects from training, diet, or seasonal changes in body composition and energy. A break of two to four weeks after an eight to twelve week cycle, or four to six weeks after a longer run, is the most commonly used pattern.

BAM15 specifically deserves a conservative approach. Because it forces mitochondria to burn fuel as heat, extended continuous use at higher doses without reassessment carries a theoretical thermogenic load concern. Most approaches treat BAM15 as the more cautious half of the stack, either using it on fewer days per week or taking periodic breaks from it even while continuing SLU-PP-332.

The off-cycle period also provides a natural reset window for anyone who experienced sleep disruption or mild side effects during the cycle.

What to Expect Week by Week

• Weeks 1 to 2: The first two weeks are typically subtle. SLU-PP-332 works through gene transcription, so effects build over time rather than arriving acutely. Some users notice a mild increase in body temperature and slight energy fluctuations. BAM15 users sometimes report elevated sleeping temperature and mild thermogenesis. A portion of users experience initial sleep disruption, which usually resolves once the morning timing is locked in. Some users report no noticeable effects in this window at all.
• Weeks 3 to 4: Endurance improvements begin to show up more consistently. Users commonly report quicker recovery between sessions, reduced breathlessness during cardio, and early body composition changes that appear in the mirror before they show on a scale.
• Weeks 5 to 8: This is the window where most meaningful changes are commonly reported. Visceral fat reduction, better muscular definition, increased work capacity, and what multiple users describe as clean energy without stimulant jitteriness or crash. Users in a caloric deficit during this window report accelerated fat loss. Some notice reduced hunger, though this is not universal.
• Beyond 8 weeks: Users who extend into a 12 to 16 week cycle commonly report sustained endurance gains and continued body composition improvement. Some report enhanced cognitive clarity in this window, described as improved focus without stimulant feel.

What a well-run cycle commonly looks like: by week 6 to 8, a user who has kept SLU-PP-332 in the morning, used BAM15 consistently on rest days, and maintained a reasonable caloric deficit tends to report leaner body composition, meaningfully better endurance output, and sustained energy during training that is distinct from caffeine-driven performance. These are the effects users most commonly describe as the reason they return to this stack.

These are commonly reported patterns drawn from community protocol data and preclinical research, not clinical trial outcomes. Individual results vary by formulation, consistency, and diet.

Common Protocol Mistakes

Starting both compounds at full dose simultaneously. The most consistent warning across community approaches is to not run both compounds at high doses from day one. The thermogenic effects of BAM15 and the mitochondrial upregulation of SLU-PP-332 together can produce excessive heat generation that makes the combination feel worse than either compound alone. Starting conservatively with one, gauging response, and layering the second is the pattern that experienced users describe as the difference between a productive cycle and one abandoned in week two.

Taking SLU-PP-332 and BAM15 on the same day at high doses. SLU-PP-332 drives ATP production by building mitochondrial capacity. BAM15 prevents ATP from being produced by dissipating the proton gradient, the pressure difference across the mitochondrial membrane that drives energy production. Running both at high doses on the same day can negate the benefit of each and push thermogenesis beyond a useful range. The split-day protocol exists specifically to prevent this.

Variable or inconsistent timing. SLU-PP-332's effectiveness is tied to circadian metabolic alignment. Taking it at different times each day or missing days disrupts the gene transcription pattern the compound is meant to establish. Multiple practitioners flag inconsistent timing as a more significant error for this compound than for many others.

Expecting scale-weight changes in the first few weeks. Community reports are consistent on this: users often feel and look leaner before the scale reflects it. Visceral fat reduction tends to show in waistline measurements and energy before it shows in body weight. Judging the protocol by the scale in weeks one to three underestimates what is actually happening.

Ignoring the unit inconsistency in community dosing sources. Community reporting for this stack contains a significant and unresolved discrepancy between doses reported in micrograms and doses reported in milligrams, a thousand-fold difference. Running a dose from a community forum without verifying the unit convention against the specific formulation is a meaningful concern for this stack in particular.

Sourcing from unverifiable suppliers and skipping training. Both compounds are research-only, and the absence of regulatory oversight means purity and concentration cannot be assumed from labeling alone. Third-party testing and verifiable chain of custody matter more for compounds like these than for more established research compounds. Neither compound is a substitute for a caloric deficit and a training stimulus: community reports consistently note that fat loss and endurance effects are substantially reduced without both. These compounds amplify metabolic work the user is already doing; they do not replace it.

Neither SLU-PP-332 nor BAM15 is FDA-approved for human use. Both are research-only compounds, and anyone competing in tested sports should independently verify their status with the relevant governing body before use.

Frequently Asked Questions

How long is a typical SLU-PP-332+BAM15 cycle?

Most cycles run 8 to 12 weeks, with a two to four week assessment period common before committing to a full cycle. Longer cycles of 12 to 16 weeks are used among more experienced users. Because neither compound works through a hormonal feedback loop, there is no physiological minimum off-cycle requirement, though most practitioners recommend a break of two to six weeks after each cycle to reassess baseline.

How often do you take SLU-PP-332+BAM15?

SLU-PP-332 is typically taken once daily in the morning. BAM15 is taken on separate days, usually rest or off-training days, on an every-other-day or three-days-per-week pattern. The split-day structure is the defining frequency feature of this combination and is designed to prevent excessive simultaneous thermogenesis.

Does SLU-PP-332+BAM15 need a loading phase?

No. Neither compound uses a traditional loading phase. The structural equivalent is titration: starting at a conservative point and moving upward gradually over the first two to four weeks based on thermogenic response. The dose reached through titration is then sustained for the remainder of the cycle.

Do you need to cycle off SLU-PP-332+BAM15?

A mandatory off-cycle is not physiologically required, because neither compound operates through a hormonal feedback loop that needs resetting. Most practitioners recommend a voluntary break of two to six weeks after each cycle to reassess baseline and distinguish compound effects from other variables.

Is SLU-PP-332 actually a peptide?

No. Despite being widely discussed in peptide biohacking communities, SLU-PP-332 is a small-molecule pan-ERR agonist, not a peptide. It activates estrogen-related receptors through gene transcription rather than through hormonal or pituitary pathways. BAM15 is similarly a small molecule, a mitochondrial uncoupler. The cycling considerations for these compounds differ from classical peptide protocols in important ways, particularly around off-cycle requirements.

Can you take SLU-PP-332 and BAM15 at the same time?

Most approaches advise against it at higher doses. Taking both simultaneously can produce excessive thermogenesis and drive mitochondrial energy dissipation beyond a useful range, potentially negating the benefit of each compound. Pre-blended capsules containing both are commercially available as research products, but most experienced users who have tried both formats report preferring the split-day approach for better control over individual effects.

Disclaimer

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world protocols for SLU-PP-332+BAM15 in one place.